StockDuty ← Dashboard Aug 14, 2026 07:53 PM ET
CatalystFDA/Bio

PROKIDNEY: DO-OR-DIE PHASE 3 MEETS A DWINDLING BALANCE SHEET (RATING DOWNGRADE) - SEEKINGALPHA

Phase 3 binary risk meets cash constraints, driving downgrade.

What changed
Why it matters
Phase 3 binary risk meets cash constraints, driving downgrade.
Sources
seekingalpha
Related signals
PHASE 1 OF INDIA - US TRADE PACT HINGES ON SECTION 301 PROBE , OFFICIAL SAYS →PITNEY BOWES OUTLINES PHASE 2 STRATEGIC REVIEW WHILE PUSHING NEAREST DEBT MATURITY TO MARCH 2029 - SEEKINGALPHA →UNICYCIVE PLUMMETS FOLLOWING SECOND CRL FOR OLC FOR HYPERPHOSPHATEMIA - SEEKINGALPHA →